Advancing mRNA-based drug development and vaccine manufacturing

Shared by Parexel experts, Christiane Niederlaender, Cecil Nick, and Sinan Sarac covering on the topics of:

Section 1 - Overview of mRNA Product Manufacturing Challenges
Section 2 - Optimizing the Path to Regulatory Approval for Novel Vaccine
Section 3 - Accelerating Approval of mRNA vaccines for Oncology Drug development

Return to Insights Center

Related Insights

Article

Q&A Project Optimus: What you need to know

Oct 11, 2022

Webinar

Navigating the complexities of AML drug development

Oct 30, 2024

Blog

PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers

Oct 4, 2024

Article

New endpoints for early-stage cancer are gaining regulatory traction

Jan 28, 2022

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Webinar

Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)

Nov 12, 2024

Playbook

Are you using real-world evidence?

Feb 1, 2023

Blog

Innovative modeling method could speed patient access to critical IO therapies

Jan 4, 2023

Article

Relyvrio Approval: Lessons Learned

Oct 31, 2022

Blog

Navigating the Joint Clinical Assessment (JCA) implementation: An analysis of EU member states readiness, challenges and opportunities for harmonization

Jan 9, 2025

Webinar

How to navigate China’s regulatory environment

Feb 15, 2023

Related Insights

Article

Q&A Project Optimus: What you need to know

Oct 11, 2022

Webinar

Navigating the complexities of AML drug development

Oct 30, 2024

Blog

PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers

Oct 4, 2024

Article

New endpoints for early-stage cancer are gaining regulatory traction

Jan 28, 2022

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Show more